| Literature DB >> 32000469 |
Yoon Suk Lee1, Chang Min Cho2, Kwang Bum Cho3, Jun Heo2, Min Kyu Jung2, Sung Bum Kim4, Kook Hyun Kim4, Tae Nyeun Kim4, Dong Wook Lee5, Jimin Han5, Ho Gak Kim5, Daejin Kim6, Hyunsoo Kim6.
Abstract
Background/Aims: Recently, the European Society of Gastrointestinal Endoscopy (ESGE) proposed criteria for "difficult biliary cannulation" during endoscopic retrograde cholangiopancreatography (ERCP). This study aimed to investigate the clinical relevance of the ESGE criteria from the perspective of post-ERCP pancreatitis (PEP).Entities:
Keywords: Cholangiopancreatography; Decision trees; Pancreatitis; Practice guideline; Risk factors; endoscopic retrograde
Year: 2021 PMID: 32000469 PMCID: PMC8129666 DOI: 10.5009/gnl19304
Source DB: PubMed Journal: Gut Liver ISSN: 1976-2283 Impact factor: 4.519
Baseline Characteristics of All Enrolled Patients
| Characteristic | Value (n=1,067) |
|---|---|
| Age, yr | 70 (19–101) |
| Female sex | 451 (42.3) |
| Indication for ERCP | |
| Choledocholithiasis | 790 (73.0) |
| Malignant biliary stricture | 238 (22.1) |
| Benign biliary stricture | 20 (1.9) |
| Post-cholecystectomy bile leakage | 11 (1.0) |
| Others | 10 (0.9) |
| Presence of periampullary diverticulum | 315 (29.5) |
| Type 1 | 46 (14.6) |
| Type 2 | 142 (45.1) |
| Type 3 | 127 (40.3) |
| Procedure time, min | |
| Overall | 16 (3–85) |
| Biliary cannulation | 5 (1–65) |
| Bile duct access | |
| Successful first attempt | 761 (70.4) |
| Failed biliary cannulation | 24 (2.2) |
| Contacts with papilla | |
| None | 597 (56.0) |
| <5 times | 357 (33.5) |
| 5–10 times | 78 (7.3) |
| ≥10 times | 35 (3.3) |
| Inadvertent PD catheter insertion | |
| None | 860 (80.6) |
| <5 times | 169 (15.8) |
| 5–10 times | 24 (2.2) |
| ≥10 times | 14 (1.3) |
| Inadvertent PD contrast injection | |
| None | 909 (85.2) |
| <5 times | 149 (14.0) |
| 5–10 times | 9 (0.8) |
| ≥10 times | 0 |
| Inadvertent PD guidewire passage | |
| None | 767 (71.9) |
| <5 times | 258 (24.2) |
| 5–10 times | 30 (2.8) |
| ≥10 times | 12 (1.1) |
| Precut sphincterotomy | 60 (5.6) |
| Infundibulotomy | 81 (7.6) |
| Endoscopic papillary balloon dilation | 131 (12.3) |
| Normal sphincterotomy | 846 (79.3) |
| Prophylactic drugs | 784 (73.5) |
| Nafamostat mesylate | 362 (33.9) |
| Ulinastin | 228 (21.4) |
| Gabexate mesylate | 194 (18.2) |
| Post-ERCP adverse events | 190 (17.8) |
| Pancreatitis | 70 (6.6) |
| Mild | 61 (87.1) |
| Moderate | 7 (10.0) |
| Severe | 2 (2.9) |
| Bleeding | 120 (11.2) |
| Intraprocedural | 114 (95.0) |
| Immediate | 3 (2.5) |
| Delayed | 3 (2.5) |
| Perforation | 7 (0.6) |
| Cholangitis | 14 (1.3) |
Data are presented as median (range) or number (%).
ERCP, endoscopic retrograde cholangiopancreatography; PD, pancreatic duct.
Univariate and Multivariate Analyses of Risk Factors for Post-ERCP Pancreatitis (n=1,067)
| Variable | Univariate analysis | Multivariate analysis | |||||
|---|---|---|---|---|---|---|---|
| With PEP | Without PEP (n=997) | p-value | Odds ratio | 95% CI | p-value | ||
| Age (≤70 yr) | 39 (55.7) | 499 (50.1) | 0.364 | ||||
| Female sex | 39 (55.7) | 412 (41.3) | 0.018 | 1.860 | 1.124–3.078 | 0.016 | |
| Periampullary diverticulum | 18 (25.7) | 297 (29.8) | 0.470 | ||||
| Failed BD access | 3 (4.3) | 21 (2.1) | 0.220 | ||||
| Overall procedure time (>10 min) | 66 (94.3) | 755 (75.7) | <0.001 | 1.916 | 0.615–5.973 | 0.262 | |
| BD cannulation (>5 min) | 56 (80.0) | 418 (41.9) | <0.001 | 3.282 | 1.641–6.566 | 0.001 | |
| Contact with papilla (>5 times) | 14 (20.0) | 99 (9.9) | 0.008 | 0.862 | 0.441–1.684 | 0.664 | |
| Inadvertent PD manipulation | 46 (65.7) | 322 (32.3) | <0.001 | 2.614 | 1.480–4.617 | 0.001 | |
| PD catheter insertion (≥1 attempt) | 26 (37.1) | 181 (18.2) | <0.001 | ||||
| PD contrast injection (≥1 event) | 19 (27.1) | 139 (13.9) | 0.003 | ||||
| PD guidewire passage (≥1 event) | 40 (57.1) | 260 (26.1) | <0.001 | ||||
| Precut sphincterotomy | 5 (7.1) | 55 (5.5) | 0.568 | ||||
| EPBD | 4 (5.7) | 127 (12.7) | 0.083 | ||||
| Mechanical lithotripsy | 4 (5.7) | 63 (6.3) | 0.840 | ||||
| ERPD | 9 (13.0) | 54 (5.4) | 0.010 | 0.963 | 0.430–2.153 | 0.926 | |
| Prophylactic drug | 59 (84.3) | 725 (72.7) | 0.034 | 1.463 | 0.735–2.912 | 0.279 | |
Data are presented as number (%).
ERCP, endoscopic retrograde cholangiopancreatography; PEP, post-ERCP pancreatitis; CI, confidence interval; BD, bile duct; PD, pancreatic duct; EPBD, endoscopic papillary balloon dilation; ERPD, endoscopic retrograde pancreatic drainage.
Fig. 1A decision tree model for the prediction of post-ERCP pancreatitis generated by classification and regression tree analysis using our ERCP database.
ERCP, endoscopic retrograde cholangiopancreatography; PEP, post-ERCP pancreatitis.
Fig. 2A decision tree model for the prediction of post-ERCP pancreatitis in the moderate-to-severe grade subgroup, generated by classification and regression tree analysis using our ERCP database.
ERCP, endoscopic retrograde cholangiopancreatography; PEP, post-ERCP pancreatitis.